Evidence map›Paper›PMID 32445087›Full record

ArticleMolecular neurobiology2020

Ferulic Acid Ameliorates MPP

Xu Li, Jing Zhang, Hua Rong, Xiaojie Zhang, Miaoxian Dong

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Sirtuins as Players in the Signal Transduction ofInternational journal of molecular sciences · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Effects of Apamin on MPPInternational journal of molecular sciences · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Nrf2 as a potential target for Parkinson's disease therapy.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xu LiThe Institute of Medicine, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China.
Jing ZhangDepartment of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.
Hua RongThe Institute of Medicine, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China.
Xiaojie ZhangThe Institute of Medicine, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China.
Miaoxian DongThe Institute of Medicine, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China. dmx1969@126.com.ORCID http://orcid.org/0000-0002-6723-2039
Qiqihar Medical University · CNHarbin Medical University · CN

Funding

National Natural Science Foundation of China 81873133
6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder closely associated with oxidative stress. The biochemical and cellular alterations that occur after cell and mouse treatment with the parkinsonism-inducing neurotoxin MPP

Indexed as

alpha-SynucleinAnimalsAntioxidantsCell Line, TumorCoumaric AcidsHumansMAP Kinase Signaling SystemMiceNF-E2-Related Factor 2Oxidative StressParkinsonian DisordersReactive Oxygen Speciesalpha-SynucleinAntioxidantsCoumaric Acidsferulic acidNfe2l2 protein, mouseNF-E2-Related Factor 2Reactive Oxygen SpeciesFerulic acidMotor deficitsNrf2Oxidative stressParkinson’s disease

Identifiers

PMID32445087
OpenAlexW3026655720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.